A
0.011
0.00 (0.00%)
| Penutupan Terdahulu | 0.011 |
| Jumlah Dagangan | 101,340 |
| Harga / Jualan (P/S) | 1.08 |
| Harga / Buku (P/B) | 4.55 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | -4,310.00% |
| EPS Cair (TTM) | -0.020 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -97.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 61.92% |
| Nisbah Semasa (MRQ) | 1.92 |
| Aliran Tunai Operasi (OCF TTM) | -4.27 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -4.06 M |
| Pulangan Atas Aset (ROA TTM) | -60.07% |
| Pulangan Atas Ekuiti (ROE TTM) | -132.33% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (AU) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | ACRUX FPO [ACR] | - | - |
AISkor Stockmoo
-0.9
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 0.0 |
| Purata | -0.93 |
|
Acrux Ltd is a dynamic Australian drug delivery specialist with expertise in developing and commercialising patient-preferred healthcare products for world-wide markets. Its talent creates value through the development and commercialisation of healthcare products using owned or acquired technologies. The group's products are patient preferred, protected by patent or other means, and use creative drug delivery. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 17.06% |
| % Dimiliki oleh Institusi | 9.98% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |